Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2020

May 20, 2020

35081_dirs_2020-05-20_e13d78d3-e770-4785-ac2d-1cc9052df0c3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2019-07-05

Reporting Person: STERTZER SIMON H (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-08-02 Common Stock P 41667 $6 Acquired 91544 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-08-02 Warrant (right to buy) $6.30 P 41667 Acquired 2024-08-06 Common Stock (41667) Indirect

Footnotes

F1: The original Form 4 omitted the issuance of these securities.

F2: The reported securities were included within 41,667 units purchased by Stertzer Holdings LLC for $6.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock.

F3: These securities are held by Stertzer Holdings LLC, and the Reporting Person may be deemed to have beneficial ownership of such securities.